ITEL Telecomunicazioni Srl: Clinical Trials

1 unknown. 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	1	Unknown 1

Follow ITEL Telecomunicazioni Srl: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine - Prostate Cancer, 18F- Fluorocholine	Phase 3	Unknown	ITEL Telecomunicazioni Srl	106	2022-12-19	2024-05-22

Conditions studied

Prostatic Neoplasms (1)

Interventions

18F-JK-PSMA-7 (1)  ·  fluorocholine (1)

Countries

Italy (1)

Results publications

PMID 15840561, PMID 20800404, PMID 21350618, PMID 21844889, PMID 23559588, PMID 23797218, PMID 24072344, PMID 24207135, PMID 24920079, PMID 25203127, PMID 25411132, PMID 25447835, PMID 27363387, PMID 28518227, PMID 30027419, PMID 30174470, PMID 30389823, PMID 30448957, PMID 30507748, PMID 31324713, PMID 31516367, PMID 31836681, PMID 31836682, PMID 34895925